Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system

Trends in Pharmacological Sciences

Volumn 36, Issue 9, 2015, Pages 560-567

  Yang, Peiran ^a   Maguire, Janet J ^a   Davenport, Anthony P ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

apelin; apelin receptor; APJ; biased agonist; Elabela Toddler; pulmonary arterial hypertension

Indexed keywords

APELIN; APELIN RECEPTOR; BETA ARRESTIN; ELABELA PEPTIDE; ML 221; MM 54; NEUROPEPTIDE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; APELIN-13 PEPTIDE; ELA PEPTIDE, HUMAN; G PROTEIN COUPLED RECEPTOR; PEPTIDE HORMONE; SIGNAL PEPTIDE;

AGONIST; CARDIOVASCULAR SYSTEM; DOWN REGULATION; HEART DEVELOPMENT; HEART LEFT VENTRICLE FAILURE; HUMAN; INTERNALIZATION; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; AGONISTS; AMINO ACID SEQUENCE; ANIMAL; CARDIOVASCULAR DISEASES; CHEMISTRY; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE HORMONES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84941317291     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2015.06.002     Document Type: Review

References (115)

1. B.F. O'Dowd, and et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11 Gene 136 1993 355 360
2. K. Tatemoto, and et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor Biochem. Biophys. Res. Commun. 251 1998 471 476
3. 1)Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man Br. J. Pharmacol. 132 2001 1255 1260
4. S.L. Pitkin, and et al. International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function Pharmacol. Rev. 62 2010 331 342
5. Y. Habata, and et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum Biochim. Biophys. Acta 1452 1999 25 35
6. M. Hosoya, and et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin J. Biol. Chem. 275 2000 21061 21067
7. A.G. Japp, and D.E. Newby The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential Biochem. Pharmacol. 75 2008 1882 1892
8. Y. Kang, and et al. Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development Circ. Res. 113 2013 22 31
9. M.C. Scimia, and et al. APJ acts as a dual receptor in cardiac hypertrophy Nature 7411 2012 394 398
10. S. Rajagopal, and et al. Teaching old receptors new tricks: biasing seven-transmembrane receptors Nat. Rev. Drug Discov. 9 2010 373 386
11. X. Iturrioz, and et al. By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization J. Biol. Chem. 285 2010 32627 32637
12. X. Chen, and et al. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling J. Biol. Chem. 289 2014 31173 31187
13. H.J. Chun, and et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis J. Clin. Invest. 118 2008 3343 3354
14. K. Siddiquee, and et al. The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition Br. J. Pharmacol. 168 2013 1104 1117
15. A.M. O'Carroll, and et al. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues Biochim. Biophys. Acta 1492 2000 72 80
16. A.D. Medhurst, and et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin J. Neurochem. 84 2003 1162 1172
17. G.R. Pope, and et al. Central and peripheral apelin receptor distribution in the mouse: species differences with rat Peptides 33 2012 139 148
18. M.J. Kleinz, and et al. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells Regul. Pept. 126 2005 233 240
19. M.J. Kleinz, and A.P. Davenport Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells Regul. Pept. 118 2004 119 125
20. 1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease Hypertension 54 2009 598 604
21. E.Y. Zhen, and et al. Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma Anal. Biochem. 442 2013 1 9
22. K. Shin, and et al. Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity FEBS Open Bio. 3 2013 328 333
23. A. Murza, and et al. Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid Biopolymers 101 2014 297 303
24. C. Vickers, and et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase J. Biol. Chem. 277 2002 14838 14843
25. Yang, P. et al. (2013) Cellular localisation and functions of the ACE2 metabolite of (Pyr1)apelin-13. Proc. 37th IUPS Congress, PCA092
26. X. Fan, and et al. Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ Biochemistry 42 2003 10163 10168
27. D.N. Langelaan, and et al. Structural insight into G-protein coupled receptor binding by apelin Biochemistry 48 2009 537 548
28. M.J. Macaluso, and R.C. Glen Exploring the 'RPRL' motif of apelin-13 through molecular simulation and biological evaluation of cyclic peptide analogues ChemMedChem 5 2010 1247 1253
29. R. Gerbier, and et al. New structural insights into the apelin receptor: identification of key residues for apelin binding FASEB J. 29 2015 314 322
30. Y. Zhang, and et al. Identifying structural determinants of potency for analogs of apelin-13: integration of C-terminal truncation with structure-activity Bioorg. Med. Chem. 22 2014 2992 2997
31. A. Murza, and et al. C-terminal modifications of apelin-13 significantly change ligand binding, receptor signaling and hypotensive action J. Med. Chem. 58 2015 2431 2440
32. J. Hamada, and et al. Evaluation of novel cyclic analogues of apelin Int. J. Mol. Med. 22 2008 547 552
33. Z.Q. Jia, and et al. Cardiovascular effects of a PEGylated apelin Peptides 38 2012 181 188
34. S.C. McKeown, and et al. The design and implementation of a generic lipopeptide scanning platform to enable the identification of 'locally acting' agonists for the apelin receptor Bioorg. Med. Chem. Lett. 24 2014 4871 4875
35. X. Iturrioz, and et al. Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist FASEB J. 24 2010 1506 1517
36. J.F. Margathe, and et al. Structure-activity relationship studies toward the discovery of selective apelin receptor agonists J. Med. Chem. 57 2014 2908 2919
37. i over β-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine J. Biol. Chem. 289 2014 24599 24610
38. A.L. Brame, and et al. Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist Hypertension 65 2015 834 840
39. P. Khan, and et al. Functional agonists of the apelin (APJ) receptor. In Probe Reports from the NIH Molecular Libraries Program 2011 National Center for Biotechnology Information
40. M.J. Macaluso, and et al. Discovery of a competitive apelin receptor (APJ) antagonist ChemMedChem 6 2011 1017 1023
41. P.R. Maloney, and et al. Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor Bioorg. Med. Chem. Lett. 22 2012 6656 6660
42. N. Zhou, and et al. Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1 Virology 312 2003 196 203
43. I. Castan-Laurell, and et al. Apelin, a promising target for type 2 diabetes treatment? Trends Endocrinol. Metab. 23 2012 234 241
44. S.Y. Lv, and et al. Regulation of feeding behavior, gastrointestinal function and fluid homeostasis by apelin Peptides 44 2013 87 92
45. A.M. O'Carroll, and et al. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis J. Endocrinol. 219 2013 R13 R35
46. M.J. Kleinz, and A.P. Davenport Emerging roles of apelin in biology and medicine Pharmacol. Ther. 107 2005 198 211
47. K. Kuba, and et al. Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload Circ. Res. 101 2007 e32 e42
48. H. Kidoya, and et al. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis EMBO J. 27 2008 522 534
49. D.N. Charo, and et al. Endogenous regulation of cardiovascular function by apelin-APJ Am. J. Physiol. Heart Circ. Physiol. 297 2009 H1904 H1913
50. J. Ishida, and et al. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo J. Biol. Chem. 279 2004 26274 26279
51. E.M. Roberts, and et al. Abnormal fluid homeostasis in apelin receptor knockout mice J. Endocrinol. 202 2009 453 462
52. T. Sato, and et al. Apelin is a positive regulator of ACE2 in failing hearts J. Clin. Invest. 123 2013 5203 5211
53. S.M. Chandra, and et al. Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension Arterioscler. Thromb. Vasc. Biol. 31 2011 814 820
54. W. Wang, and et al. Loss of apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic apelin analogues J. Am. Heart Assoc. 2 2013 e000249
55. Y. Kojima, and et al. Upregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouse Cardiovasc. Res. 87 2010 156 165
56. S.C. Chng, and et al. ELABELA: a hormone essential for heart development signals via the apelin receptor Dev. Cell 27 2013 672 680
57. A. Pauli, and et al. Toddler: an embryonic signal that promotes cell movement via Apelin receptors Science 343 2014 1248636
58. A. Pauli, and et al. Identifying (non-)coding RNAs and small peptides: challenges and opportunities Bioessays 37 2015 103 112
59. P. Yang, and et al. ELABELA/Toddler, a critical regulator of cardiac development, is expressed in the human cardiovascular system and binds the apelin receptor Circulation 130 2014 A15352
60. Z. Wang, and et al. Elabela-Apelin receptor signaling pathway is functional in mammalian systems Sci. Rep. 5 2015 8170
61. A.G. Japp, and et al. Vascular effects of apelin in vivo in man J. Am. Coll. Cardiol. 52 2008 908 913
62. D.K. Lee, and et al. Characterization of apelin, the ligand for the APJ receptor J. Neurochem. 74 2000 34 41
63. K. Tatemoto, and et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism Regul. Pept. 99 2001 87 92
64. X. Cheng, and et al. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats Eur. J. Pharmacol. 470 2003 171 175
65. A.G. Japp, and et al. Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure Circulation 121 2010 1818 1827
66. A. Salcedo, and et al. Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids Regul. Pept. 144 2007 50 55
67. Y.X. Jia, and et al. Apelin activates L-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas Peptides 28 2007 2023 2029
68. T. Hashimoto, and et al. Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 26 2006 1267 1272
69. + channels in cerebral artery smooth muscle cells via a PI3-kinase dependent mechanism PLoS ONE 8 2013 e83051
70. L. Dai, and et al. Apelin acts in the subfornical organ to influence neuronal excitability and cardiovascular function J. Physiol. 591 2013 3421 3432
71. B. Gurzu, and et al. Interactions between apelin and angiotensin II on rat portal vein J. Renin Angiotensin Aldosterone Syst. 7 2006 212 216
72. M.F. Berry, and et al. Apelin has in vivo inotropic effects on normal and failing hearts Circulation 110 Suppl. 1 2004 187 193
73. Y.X. Jia, and et al. Apelin protects myocardial injury induced by isoproterenol in rats Regul. Pept. 133 2006 147 154
74. P. Atluri, and et al. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression Cell. Mol. Biol. Lett. 12 2007 127 138
75. E.A. Ashley, and et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo Cardiovasc. Res. 65 2005 73 82
76. I. Szokodi, and et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility Circ. Res. 91 2002 434 440
77. A. Perjés, and et al. Apelin increases cardiac contractility via protein kinase and extracellular signal-regulated kinase-dependent mechanisms PLoS ONE 9 2014 e93473
78. K. Farkasfalvi, and et al. Direct effects of apelin on cardiomyocyte contractility and electrophysiology Biochem. Biophys. Res. Commun. 357 2007 889 895
79. T. Dai, and et al. Apelin increases contractility in failing cardiac muscle Eur. J. Pharmacol. 553 2006 222 228
80. i transient and contractions during twitches in isolated rat cardiac myocytes Am. J. Physiol. Heart Circ. Physiol. 294 2008 H2540 H2546
81. I.C. Scott, and et al. The G protein-coupled receptor Agtrl1b regulates early development of myocardial progenitors Dev. Cell 12 2007 403 413
82. X.X. Zeng, and et al. Apelin and its receptor control heart field formation during zebrafish gastrulation Dev. Cell 12 2007 391 402
83. C. D'Aniello, and et al. G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/p70S6 kinase signaling pathway Circ. Res. 105 2009 231 238
84. A. Kasai, and et al. Apelin is a novel angiogenic factor in retinal endothelial cells Biochem. Biophys. Res. Commun. 325 2004 395 400
85. C.M. Cox, and et al. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo Dev. Biol. 296 2006 177 189
86. X.H. Yu, and et al. Apelin and its receptor APJ in cardiovascular diseases Clin. Chim. Acta. 428 2014 1 8
87. M. Toshner, and et al. Pulmonary hypertension: advances in pathogenesis and treatment Br. Med. Bull. 94 2010 21 32
88. J.P. Goetze, and et al. Apelin: a new plasma marker of cardiopulmonary disease Regul. Pept. 133 2006 134 138
89. J. Kim, and et al. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension Nat. Med. 19 2013 74 82
90. T.P. Alastalo, and et al. Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival J. Clin. Invest. 121 2011 3735 3746
91. T. Bertero, and et al. Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension J. Clin. Invest. 124 2014 3514 3528
92. C.U. Andersen, and et al. Pulmonary apelin levels and effects in rats with hypoxic pulmonary hypertension Respir. Med. 103 2009 1663 1671
93. I. Falcão-Pires, and et al. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension Am. J. Physiol. Heart Circ. Physiol. 296 2006 H2007 H2014
94. E. Spiekerkoetter, and et al. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension J. Clin. Invest. 123 2013 3600 3613
95. N.P. Nickel, and et al. Elafin reverses pulmonary hypertension via caveolin-1 dependent bone morphogenetic protein signaling Am. J. Respir. Crit. Care Med. 191 2015 1273 1286
96. M.H. Helenius, and et al. Suppression of endothelial CD39/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension Am. J. Physiol. Lung Cell. Mol. Physiol. 308 2015 L1046 L1057
97. M.M. Chen, and et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction Circulation 108 2003 1432 1439
98. K.H. Miettinen, and et al. Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy Regul. Pept. 140 2007 178 184
99. G. Földes, and et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure Biochem. Biophys. Res. Commun. 308 2003 480 485
100. K.S. Chong, and et al. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure Eur. J. Heart Fail. 8 2006 355 360
101. P. Francia, and et al. Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin Eur. J. Heart Fail. 9 2007 306 309
102. Y. Iwanaga, and et al. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system J. Mol. Cell. Cardiol. 41 2006 798 806
103. W. Koguchi, and et al. Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure Circ. J. 76 2011 137 144
104. M. Wang, and et al. Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure J. Card. Fail. 19 2013 509 516
105. R. Sarzani, and et al. The 212A variant of the APJ receptor gene for the endogenous inotrope apelin is associated with slower heart failure progression in idiopathic dilated cardiomyopathy J. Card. Fail. 13 2007 521 529
106. H. Pang, and et al. Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure Int. J. Mol. Med. 34 2014 756 764
107. C. Foussal, and et al. Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy FEBS Lett. 584 2010 2363 2370
108. G.D. Barnes, and et al. Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure Circ. Heart Fail. 6 2013 482 491
109. V.P. Ronkainen, and et al. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin FASEB J. 21 2007 1821 1830
110. M.J. Kleinz, and G.F. Baxter Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase Regul. Pept. 146 2008 271 277
111. J.C. Simpkin, and et al. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury Basic Res. Cardiol. 102 2007 518 528
112. X.J. Zeng, and et al. Apelin protects heart against ischemia/reperfusion injury in rat Peptides 30 2009 1144 1152
113. J. Tao, and et al. Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion Am. J. Physiol. Heart Circ. Physiol. 301 2011 H1471 H1486
114. Y. Azizi, and et al. Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction Peptides 46 2013 76 82
115. A.P. Davenport, and et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands Pharmacol. Rev. 65 2013 967 986